The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial.
 
Ari Rosenberg
Stock and Other Ownership Interests - Galectin Therapeutics; Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Nanobiotix; Novartis; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Hookipa Biotech (Inst); Sysmex (Inst)
 
Aditya Juloori
Consulting or Advisory Role - AquaLung Therapeutics; General Electric; Isoray
Research Funding - AstraZeneca
 
Nishant Agrawal
Stock and Other Ownership Interests - Haystack Oncology; OrisDX; Privo Technologies
Patents, Royalties, Other Intellectual Property - Patent pending for salivary diagnostics to diagnose oral cancer.
 
John Cursio
No Relationships to Disclose
 
Michael J. Jelinek
No Relationships to Disclose
 
Nicole Cipriani
No Relationships to Disclose
 
Mark W. Lingen
No Relationships to Disclose
 
Rachelle Wolk
No Relationships to Disclose
 
Jeffrey Chin
No Relationships to Disclose
 
Melody Jones
No Relationships to Disclose
 
Daniel Ginat
No Relationships to Disclose
 
Olga Pasternak-Wise
No Relationships to Disclose
 
Zhen Gooi
No Relationships to Disclose
 
Elizabeth A. Blair
No Relationships to Disclose
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I); Privo Technologies
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); Kura Oncology (Inst)
 
Daniel J. Haraf
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals; McKesson
Honoraria - Ascendis Pharma (I)
Consulting or Advisory Role - Ascendis Pharma (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Lilly (Inst); Novartis